홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

(3R*,4R*)-1-[(1-acetylpiperidin-4-yl)carbonyl]-3-(3,4-dichlorophenyl)-N-methylpiperidin-4-amine → N-[(3R,4R)-1-[(1-acetylpiperidin-4-yl)carbonyl]-3-(3,4-dichlorophenyl)piperidin-4-yl]-6-methoxy-N,1-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxamide

HRID 1260954
노트
인쇄 미리보기

반응식

HRID 1260954 반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][C:12]=1[C:13]([OH:15])=O)[N:9]([CH3:16])[C:8](=[O:17])[CH2:7][CH2:6]2.[C:18]([N:21]1[CH2:26][CH2:25][CH:24]([C:27]([N:29]2[CH2:34][CH2:33][C@@H:32]([NH:35][CH3:36])[C@H:31]([C:37]3[CH:42]=[CH:41][C:40]([Cl:43])=[C:39]([Cl:44])[CH:38]=3)[CH2:30]2)=[O:28])[CH2:23][CH2:22]1)(=[O:20])[CH3:19]>>[C:18]([N:21]1[CH2:22][CH2:23][CH:24]([C:27]([N:29]2[CH2:34][CH2:33][C@@H:32]([N:35]([CH3:36])[C:13]([C:12]3[CH:11]=[C:10]4[C:5]([CH2:6][CH2:7][C:8](=[O:17])[N:9]4[CH3:16])=[CH:4][C:3]=3[O:2][CH3:1])=[O:15])[C@H:31]([C:37]3[CH:42]=[CH:41][C:40]([Cl:43])=[C:39]([Cl:44])[CH:38]=3)[CH2:30]2)=[O:28])[CH2:25][CH2:26]1)(=[O:20])[CH3:19]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 57741761(3R*,4R*)-1-[(1-acetylpiperidin-4-yl)carbonyl]-3-(3,4-dichlorophenyl)-N-methylpiperidin-4-amineHCID 689356186-Methoxy-1-methyl-2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid

생성물 1

HCID 68933811N-[(3R,4R)-1-[(1-acetylpiperidin-4-yl)carbonyl]-3-(3,4-dichlorophenyl)piperidin-4-yl]-6-methoxy-N,1-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxamide

실험 절차

Using the compound obtained in step 1 and the compound obtained in Example 78, and by the reaction and purification in the same manner as in Example 3, the title compound was obtained.

출처 및 근거

ORD 기록
ord-a863c599924d4c0b9757272343909be9
출처 데이터셋
uspto-grants-2013_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08470816B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트